Skip to content

Immediate Implant Using an Inverted Co-Axis at 12º Versus a Conventional Conical Implant

Immediate Implant Using an Inverted Co-Axis at 12º Versus a Conventional Conical Implant: A Randomised Clinical Trial With 1 Year Follow-up

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06059105
Enrollment
30
Registered
2023-09-28
Start date
2022-03-15
Completion date
2024-09-15
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant Failed

Keywords

co-axis implant, dental implant, implant angulation, success rate, marginal bone loss

Brief summary

This study is a randomised controlled clinical trial. The patients will be included for the placement of immediate implants with immediate crown placement, to replace maxillary anterior teeth. Any significant differences between the Co-Axis implant and a conventional conical implant will be evaluated.

Detailed description

Introduction: It is commonly known that the placement of an immediate implant is a technique-sensitive procedure, as the implant should be placed in the palatal aspect for the perfect prosthetic emergence and profile. In order to supply this complexity, there is a novel macroimplant design involving an implant with a 12º angled platform. This angulation of the coronal part of the implant allows perfect emergence of the placement of post-extraction implants, since it is placed at the center of the socket, acquiring the best possible bone. In addition, thanks to the angled neck, prosthetic emergence is ideal, as it is corrected and emerges through the cingulate area, thus securing a perfect emergence profile. Objectives: Primary Outcomes: Evaluate the percentage of success and survival of the Inverted Co-Axis 12º Southern Implants versus the Internal Conical (Deep Tapered Conical) South Implants on a 1-2-1 follow-up. Secondary Outcomes: 1. To evaluate the primary stability of both implant systems through a coefficient stability if implants using the Penguin RFA; 2. To evaluate the horizontal and vertical marginal bone loss via a CBCT, 1 year after implant placement; 3. To evaluate the soft tissues via the Pink Esthetic Score (PES) 1 year post-op. Materials and Methods: Patients were randomly assigned in 2 groups of 15 patients, conical or inverta co-axis implants. Immediate implants in the aesthetic zone of the superior maxilar were placed with an immediate provisional crown restoration. In the same surgery, a connective tissue graft was performed. Only type I sockets according to the Elian Classification were eligible for this study.

Interventions

Inverted Co-Axis 12º Southern Implants

Sponsors

Universitat Internacional de Catalunya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The patients will be randomized into two groups. The test group (n=15) will be treated with the Inverta Co-Axis 12º implant (Southern Implants). In the control group (n=15) the Internal Conical implants (Southern implants) will be used. The difference between both implants lies in the fact that the Inverta Co-Axis 12º implant presents two different variants to the classic implant with parallel walls (Internal Conical)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients who presented with a good well-being status and no contraindication for undergoing an oral surgical procedure * Patients aged 18 and over * Adequate oral hygiene, with patient's presenting a plaque index lower than 15% using the Index Scale publish by Löe et al. * Patients who demonstrated motivation and compiled by attending the allocated follow-up appointments * One single tooth indicated to be extracted due to having a poor prognosis in the maxilla (central or lateral incisors, canines or premolars) * Absence of vestibular dehiscence in the bone table and presence of soft tissue without recession (Alveolus type I according to the classification of Elian et al. which could be determined on the day of surgery * Sufficient bone to allow implant placement with primary stability * To avoid image blurring or artefacts during CBCT, patients were included if they did not have a bridge or amalgam restoration close to the implant placement.

Exclusion criteria

* If the patient presented with an acute infection in the tooth where the implant is to be placed * Absence of posterior sector in which it would cause an occlusal overload * Alveolus with enough space to place an implant with a diameter of 4.5mm (since implants with a 3.5 coronal diameter have a widening in the middle third of the implant of 4.5mm) * Patients with an unstable periodontal status * Patients who smoked more than 10 cigarettes a day * Patients who had medical histories which contraindicate implant surgery.

Design outcomes

Primary

MeasureTime frameDescription
Success Rate1 yearICOI Pisa Implant quality of Health Criteria
Survival Rate1 yearthe implant is still in mouth,

Secondary

MeasureTime frameDescription
Horizontal and Vertical bone Changes1 yearThree CBCT will be made (CBCT 1- before implant placement, CBCT 2- just after implant placement, CBCT 3- 1 year before implant placement). First year bone loss overlap CBCT 1, 2 and 3. The horizontal bone changes will be from the implant platform at 1, 3 and 5mm from it. The vertical measurements will be from implant platform till the most vestibular and palatal bone peak.
Implant primary stabilityRight after the implant placementRecorded using Penguin RFA device
Status of the soft tissuesAt 1 yearThe Pink Esthetic Score (PES) is based on seven variables: mesial papilla, distal papilla, soft tissue contour, gingival margin level, alveolar process deficiency, soft tissue colour and texture. Each variable will be evaluated with a score of 2-1-0, with 2 being the best score and 0 the worst score. The maximum score, which reflects a perfect coincidence of the peri-implant soft tissue with that of the reference tooth, is 14.

Countries

Spain

Contacts

Primary ContactAndrea Galve
andreagalve@UIC.es+34659051487
Backup ContactJavier Gamon
jgamon@uic.es+34627321249

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026